| Chi, Hao, Xu, Jiayu and Deng, Youping 2026. AI-powered clinical decision support tools. JAMA Network Open 10.1001/jama.2026.15619 |
|
Chi, Hao, Liu, Xin, Yan, Yalan, Wang, Lexin, Luo, Peng and Xu, Jiayu
2026.
Trustworthy AI for disease pathogenesis and precision medicine: A disease-agnostic framework from data to deployment.
Genes & diseases
, 102480.
10.1016/j.gendis.2026.102480
|
|
|
Xu, Heng, Lu, Jiaan, Wang, Zizhang, Xu, Jiayu, Peng, Shihui, Chen, Haiqing, Cao, Qiang, Sun, Qing and Huang, Shangke
2026.
Targeting the neuro-immune axis in next-generation oncology: Discovery and validation of β2-adrenergic blockade to reverse ecosystem-wide resistance.
Oncology Research : Featuring Preclinical and Clincal Cancer Therapeutics
34
(9)
10.32604/or.2026.083919
|
|
|
Zhang, Lanyue, Su, Lanqian, Zhao, Jiangnan, Xu, Jiayu, Xu, Ke and Chi, Hao
2026.
The death code in nanomessengers: Mechanisms and advances in the regulation of programmed cell death by exosomes.
Life Sciences
398
, 124456.
10.1016/j.lfs.2026.124456
|
|
|
| Chi, Hao, Xu, Jiayu and Deng, Youping 2026. BRCA1P1 immunotherapy requires pseudogene-aware transcriptomics [Letter]. Proceedings of the National Academy of Sciences 123 (29) , e2616714123. 10.1073/pnas.2616714123 |
|
|
Liu, Yang, Chen, Qingxin, Xu, Jiayu and Chi, Hao
2026.
Programmed cell death in lung cancer: mechanisms, immune responses, and therapeutics.
Apoptosis
31
, 128.
10.1007/s10495-026-02298-y
|
|
|



Up a level